Jacob Ma-Weaver - Jun 15, 2022 Form 4 Insider Report for ARCA biopharma, Inc. (ABIO)

Role: Director, Other*, 10%+ Owner
Signature: /s/ Jacob Ma-Weaver
Stock symbol: ABIO
Transactions as of: Jun 15, 2022
Transactions value $: $0
Form type: 4
Date filed: 6/21/2022, 07:42 PM
Next filing: Jan 31, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	ABIO	Common Stock						2.58M	Jun 15, 2022	By the Funicular Fund	F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ABIO	Stock Option (right to buy)	Award	$0	+12K		$0.00	12K	Jun 15, 2022	Common Stock	12K	$2.27	Direct	F1, F3, F4
holding	ABIO	Put Option						1.45M	Jun 15, 2022	Common Stock	1.45M	$2.50	By the Funicular Fund	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This Form 4 is filed by Jacob Ma-Weaver (the "Reporting Person"). The Reporting Person, the Funicular Fund (the "Fund") and Cable Car Capital LLC ("Cable Car") may be deemed to be a member of a Section 13(d) group that may be deemed to collectively beneficially own more than 10% of the Issuer's outstanding shares of Common Stock (the "Shares"). Each of the Reporting Person, the Fund and Cable Car disclaim beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein.
F2	Represents securities directly owned by the Fund. Cable Car, as the general partner of the Fund, may be deemed to beneficially own the securities directly owned by the Fund. Mr. Ma-Weaver, as the Managing Member of Cable Car, may be deemed to beneficially own the securities directly owned by the Fund.
F3	Grant to the Reporting Person of a stock option under the 2020 Equity Incentive Plan (the Plan), vesting in 36 equal monthly installments from the date of grant, provided that the Reporting Person's continuous service to the Issuer has not been terminated as defined in or as determined under the Plan prior to such time. In the event of a change in control of the Issuer, 50% of the unvested options shall become fully and immediately vested upon the closing date of such change in control, provided, however, that on the earlier of (i) the one-year anniversary of the closing date or (ii) involuntary termination, any options that remain unvested on such earlier date shall become fully and immediately vested.
F4	Pursuant to the terms of the Plan, the stock option may not be transferred. Upon vesting, the Reporting Person intends on exercising the option and assigning the underlying shares to the Fund.